Dovitinib lactate hydrate, CAS [[915769-50-5]]

Produktübersicht

• Artikelname: Dovitinib lactate hydrate, CAS [[915769-50-5]]
• Artikelnummer: BYT-ORB1300733
• Hersteller Artikelnummer: orb1300733
• Alternativnummer: BYT-ORB1300733-1, BYT-ORB1300733-10, BYT-ORB1300733-100, BYT-ORB1300733-200, BYT-ORB1300733-25, BYT-ORB1300733-5, BYT-ORB1300733-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Dovitinib (TKI258) Lactate, Dovitinib Lactate, Dovitinib lactate hydrate, Dovitinib lactate Hydrate, Cluster of differentiation antigen 135, CHIR-258 lactate, CD135, CD117, cKit, c-Kit, inhibit, multi-targeted, kinase, Platelet-derived growth factor receptor, PDGFRalpha, PDGFRbeta, PDGFR, Inhibitor, FLT3, Fibroblast growth factor receptor, Fms like tyrosine kinase 3, FGFR, FGFR1, FGFR3, SCFR, tyrosine, TKI 258, TKI258, TKI-258, TKI258 lactate, Vascular endothelial growth factor receptor, VEGFR2, VEGFR1, VEGFR, VEGFR3, VEGFR3/FLT4

Produktbeschreibung

Dovitinib lactate hydrate (TKI258) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor with high potency against class III (FLT3, c-Kit), class IV (FGFR1/3), and class V (VEGFR1-4) receptors. It has been used in preclinical research, including in vitro cell-based assays and in vivo xenograft models, to study angiogenesis and oncogenic signaling in various cancers.

Produkteigenschaften

• Molekulargewicht: 482.51
• Reinheit: 99.82% (May vary between batches)
• CAS Nummer: [915769-50-5]
• Formel: C24H27FN6O4
• Target-Kategorie: VEGFR,c-Kit,FGFR,FLT,PDGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:61 mg/mL (126.42 mM),Ethanol:1 mg/mL (2.07 mM),DMSO:13.89 mg/mL (28.79 mM)